Closing

Do GLP-1 receptor agonists improve quality of life & behaviour versus placebo?

Mostly studied in type 2 & unspecified diabetes. Also asked against other treatments.

Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →

Where the evidence stands

Doubtful. So far, the results disagree.

NoUnsureYes
Belief
0.37 (range 0.00–0.55)
Trials for
3
Trials against
5
Inconclusive
3

Already under way

The evidence so far

Registered trials
289
With posted results
78
Published papers
8

Of 59 decided analyses: 14 favor glp-1 receptor agonists, 37 find no difference, 8 favor the comparator.

Papers

Trials

See every trial in the evidence map →